- Home
- SKE vs CERT Comparison
SKE vs CERT Comparison
Compare SKE & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKE
- CERT
- Stock Information
- Founded
- SKE 1979
- CERT 2008
- Country
- SKE Canada
- CERT United States
- Employees
- SKE N/A
- CERT N/A
- Industry
- SKE Precious Metals
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- SKE Basic Materials
- CERT Technology
- Exchange
- SKE Nasdaq
- CERT Nasdaq
- Market Cap
- SKE 2.0B
- CERT 1.9B
- IPO Year
- SKE N/A
- CERT 2020
- Fundamental
- Price
- SKE $17.65
- CERT $12.90
- Analyst Decision
- SKE
- CERT Buy
- Analyst Count
- SKE 0
- CERT 8
- Target Price
- SKE N/A
- CERT $15.43
- AVG Volume (30 Days)
- SKE 939.3K
- CERT 2.0M
- Earning Date
- SKE 11-13-2025
- CERT 11-05-2025
- Dividend Yield
- SKE N/A
- CERT N/A
- EPS Growth
- SKE N/A
- CERT N/A
- EPS
- SKE N/A
- CERT 0.05
- Revenue
- SKE N/A
- CERT $405,755,000.00
- Revenue This Year
- SKE N/A
- CERT $11.71
- Revenue Next Year
- SKE N/A
- CERT $8.14
- P/E Ratio
- SKE N/A
- CERT $271.10
- Revenue Growth
- SKE N/A
- CERT 11.61
- 52 Week Low
- SKE $7.32
- CERT $8.64
- 52 Week High
- SKE $19.33
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- SKE 51.86
- CERT 61.01
- Support Level
- SKE $16.85
- CERT $13.01
- Resistance Level
- SKE $18.49
- CERT $13.88
- Average True Range (ATR)
- SKE 0.78
- CERT 0.54
- MACD
- SKE -0.15
- CERT 0.15
- Stochastic Oscillator
- SKE 37.33
- CERT 63.45
About SKE Skeena Resources Limited
Skeena Resources Ltd is a mining company in development stage focusing on the construction and development of the Eskay Creek project in British Columbia. Eskay Creek is the next global gold development project and represents one of the highest-grade and lowest-cost open-pit precious metals mines, with substantial silver by-product production.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.